Literature DB >> 20418068

Serum IL-22 correlates with psoriatic severity and serum IL-6 correlates with susceptibility to phototherapy.

Yuan-Hsin Lo, Kan Torii, Chiyo Saito, Takuya Furuhashi, Akira Maeda, Akimichi Morita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20418068     DOI： 10.1016/j.jdermsci.2010.03.018

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN： 0923-1811            Impact factor:   4.563


× No keyword cloud information.
  29 in total

1.  Assessment of immunological profile in ankylosing spondylitis patients following a clinical trial with guluronic acid (G2013), as a new NSAID with immunomodulatory properties.

Authors:  Seyed Shahabeddin Mortazavi-Jahromi; Sepideh Nazeri; Fahimeh Jafarnezhad-Ansariha; Mona Oraei; Abbas Mirshafiey
Journal:  Immunol Res       Date:  2019-02       Impact factor: 2.829

2.  Different levels of circulating Th22 cell and its related molecules in Graves' disease and Hashimoto's thyroiditis.

Authors:  Rong-Hua Song; Zhi-Yun Yu; Qiu Qin; Xuan Wang; Fatuma-Said Muhali; Liang-Feng Shi; Wen-Juan Jiang; Ling Xiao; Dan-Feng Li; Jin-An Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

3.  Expressions of IL-22 in circulating CD4+/CD8+ T cells and their correlation with disease activity in SLE patients.

Authors:  Wei-Zi Qin; Li-Li Chen; Hai-Feng Pan; Rui-Xue Leng; Zhi-Min Zhai; Chao Wang; Ruo-Jie Li; Song Wang; Hui-Ping Wang; Dong-Qing Ye
Journal:  Clin Exp Med       Date:  2011-04-13       Impact factor: 3.984

4.  ILC3 cells promote the proliferation and invasion of pancreatic cancer cells through IL-22/AKT signaling.

Authors:  X Xuan; J Zhou; Z Tian; Y Lin; J Song; Z Ruan; B Ni; H Zhao; W Yang
Journal:  Clin Transl Oncol       Date:  2019-06-15       Impact factor: 3.405

5.  Glycyrrhizin combined with acitretin improve clinical symptom of psoriasis via reducing Th17 cell differentiation and related serum cytokine concentrations.

Authors:  Wen-Zhong Wu; Fu-Ren Zhang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

6.  Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis.

Authors:  Lei Zhang; Jian-Min Li; Xin-Guang Liu; Dao-Xin Ma; Nai-Wen Hu; Yong-Gang Li; Wei Li; Yu Hu; Shuang Yu; Xun Qu; Mei-Xiang Yang; A-Lei Feng; Guang-Hui Wang
Journal:  J Clin Immunol       Date:  2011-05-10       Impact factor: 8.317

Review 7.  Interleukin-22: immunobiology and pathology.

Authors:  Jarrod A Dudakov; Alan M Hanash; Marcel R M van den Brink
Journal:  Annu Rev Immunol       Date:  2015-02-11       Impact factor: 28.527

8.  Etanercept downregulates the Th17 pathway and decreases the IL-17+/IL-10+ cell ratio in patients with psoriasis vulgaris.

Authors:  Emiliano Antiga; Walter Volpi; Elisa Cardilicchia; Laura Maggi; Lucia Filì; Cinzia Manuelli; Paola Parronchi; Paolo Fabbri; Marzia Caproni
Journal:  J Clin Immunol       Date:  2012-06-15       Impact factor: 8.317

Review 9.  Emerging role of interleukin-22 in autoimmune diseases.

Authors:  Hai-Feng Pan; Xiang-Pei Li; Song Guo Zheng; Dong-Qing Ye
Journal:  Cytokine Growth Factor Rev       Date:  2012-08-18       Impact factor: 7.638

10.  22 again: IL-22 as a risk gene and important mediator in psoriasis.

Authors:  Andrew Johnston; Johann E Gudjonsson
Journal:  J Invest Dermatol       Date:  2014-06       Impact factor: 8.551
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.